icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
EDP-514, a Novel HBV Core Inhibitor with
Potent Antiviral Activity both In Vitro and In Vivo

 
 
  EASL 2019
Reported by Jules Levin

0605191

0605192

0605193

0605194

0605195

0605196

0605197

0605198

0605199